TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, ...
Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
Effect of genetically engineered Salmonella typhimurium secreting conantokin G on PD-L1 antibody therapy and tumor regression in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
NEW YORK, NY, UNITED STATES, September 17, 2024 /EINPresswire.com/ -- Basepair, a pioneer in point & click bioinformatics, announced today it is partnering with ...
Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally ...
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights. By adopting best ...